Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial,” published online February 20, 2020, and also in the April 2020 print issue of JAMA Oncology,1 the affiliations for the 17th and 18th authors were incomplete. In addition, Dr Gatti’s departmental affiliation should have been identified as “Division” instead of “Department.” Thus, in the Author Affiliations subsection of the Article Information section, the affiliation for Giovanni Grignani, MD, should have been given as “Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy,” and the affiliation for Marco Gatti, MD, should have appeared as “Division of Radiotherapy, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.” This article was corrected online.
Incomplete Affiliations Given for 2 Authors. JAMA Oncol. 2020;6(10):1641. doi:10.1001/jamaoncol.2020.4158
Create a personal account or sign in to: